Palvella Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Palvella Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- PVLA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001583648
Board of directors
-
Ann Barbier · DirectorSince 2023
-
Christopher P. Kiritsy · DirectorSince 2023
-
Elaine J. Heron · DirectorSince 2024
-
George M. Jenkins · DirectorSince 2024
-
James A. Geraghty · DirectorSince 2023
-
John Doux · DirectorSince 2026
-
Matthew L. Sherman · DirectorSince 2023
-
Matthew Pauls · DirectorSince 2026
-
Maya R. Said · DirectorSince 2023
-
Michael Richman · DirectorSince 2023
-
Peter A. Kiener · DirectorSince 2023
-
Stephen S. Yoder · Director · Chief Executive OfficerSince 2023
-
Tadd S. Wessel · DirectorSince 2024
-
Todd C. Davis · DirectorSince 2024
-
Wes Kaupinen · Director · President and CEOSince 2024
Chief executives
Wes Kaupinen
· President and CEO
Since December 2024
Stephen S. Yoder
· Chief Executive Officer
Until December 2024
· Former
Board connections
6 of this board's directors also sit on 8 other boards.
- via Matthew Pauls and Todd C. Davis
- via Elaine J. Heron
- via Peter A. Kiener
- via James A. Geraghty
- via Todd C. Davis
- via Michael Richman
- via Matthew Pauls
- via James A. Geraghty
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $849,974
- 3 purchases by 2 insiders
- Sold, last 12 months
- $4,851,559
- 30 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Option exercise | +2,154 | $7.14 | $15,380 |
| Aug 19, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Option exercise | +2,148 | $9.08 | $19,504 |
| Aug 19, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −1,500 | $151.39 | $227,085 |
| Aug 19, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −1,998 | $151.80 | $303,292 |
| Aug 19, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −400 | $153.00 | $61,199 |
| Aug 19, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −102 | $155.59 | $15,870 |
| Aug 19, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −302 | $156.77 | $47,345 |
| Jul 15, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Option exercise | +2,154 | $7.14 | $15,380 |
| Jul 15, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Option exercise | +2,148 | $9.08 | $19,504 |
| Jul 15, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −522 | $147.14 | $76,805 |
| Jul 15, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −840 | $148.40 | $124,658 |
| Jul 15, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −1,029 | $149.27 | $153,595 |
| Jul 15, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Open-market sale | −1,911 | $150.25 | $287,133 |
| Jun 17, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Option exercise | +2,154 | $7.14 | $15,380 |
| Jun 17, 2026 | Goin Kathleen Officer (Chief Operating Officer) | Option exercise | +2,148 | $9.08 | $19,504 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.